Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1458483 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Thalidomide;   Drug: Prednisone;   Biological: bevacizumab;   Genetic: polymorphism analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years